Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis

QR Code

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis

Masahiko Mihara1, Yoshiyuki Ohsugi2, Tadamitsu Kishimoto31Product Research Department, Chugai Pharmaceutical Co Ltd, Fuji-Gotemba Research Laboratories, Shizuoka, Japan; 2Chugai Pharmaceutical Co Ltd, Tokyo, Japan; 3Laboratory of Immunoregulation, Graduate School of Frontier Biosciences, Osaka Unive...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Masahiko Mihara, Yoshiyuki Ohsugi, Tadamitsu Kishimoto
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2011
Sujets:	Diseases of the musculoskeletal system RC925-935
Accès en ligne:	https://doaj.org/article/12b0bcddd7234a7d999bf1771ed9a2a2
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

The impact of tocilizumab on physical function and quality of life in patients with rheumatoid arthritis: a systematic literature review and interpretation
par: Townes SV, et autres
Publié: (2012)

Tocilizumab in the treatment of systemic juvenile idiopathic arthritis
par: Murakami M, et autres
Publié: (2012)

Pain: A Review of Interleukin-6 and Its Roles in the Pain of Rheumatoid Arthritis
par: Sebba A
Publié: (2021)

Rheumatoid arthritis: Disease or syndrome?
par: Jessica A Stanich, et autres
Publié: (2009)

Serum anticyclic citrullinated protein antibody titers are correlated with the response to biological agents in patients with rheumatoid arthritis
par: Takahashi R, et autres
Publié: (2014)

Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis
par: Peter BB Jones, et autres
Publié: (2010)

Genetics of rheumatoid arthritis: GWAS and beyond
par: McAllister KM, et autres
Publié: (2011)

Update on the use of rituximab for intractable rheumatoid arthritis
par: R John Looney
Publié: (2009)

Certolizumab in the long-term treatment of rheumatoid arthritis
par: Scott DL, et autres
Publié: (2011)

Optimal dose of etanercept in the treatment of rheumatoid arthritis
par: Curtis EM, et autres
Publié: (2014)

Rheumatoid arthritis-associated interstitial lung disease
par: Brown KK, et autres
Publié: (2012)

Long-term treatment of rheumatoid arthritis with adalimumab
par: Murdaca G, et autres
Publié: (2013)

New and emerging therapies for the treatment of rheumatoid arthritis
par: Michael G Feely
Publié: (2010)

Goals for rheumatoid arthritis: treating to target or treating to prevent?
par: Yang M, et autres
Publié: (2012)

Efficacy, safety, and tolerability of abatacept in the management of rheumatoid arthritis
par: Joseph R Lutt
Publié: (2009)

Critical appraisal of efficacy and safety of abatacept in the treatment of refractory rheumatoid arthritis
par: Augustine JM, et autres
Publié: (2012)

Association of periodontitis with rheumatoid arthritis and atherosclerosis: Novel paradigms in etiopathogeneses and management?
par: Mena Soory
Publié: (2010)

The use of administrative health care databases to identify patients with rheumatoid arthritis
par: Hanly JG, et autres
Publié: (2015)

Patients’ Perceptions of Person‐Centered Care in Early Rheumatoid Arthritis: A Qualitative Study
par: Ellen Landgren, et autres
Publié: (2021)

Bioboosters in the treatment of rheumatic diseases: a comprehensive review of currently available biologics in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
par: Fabrizio Cantini, et autres
Publié: (2009)

Prioritizing the patient: optimizing therapy in rheumatoid arthritis. Results of a patient questionnaire in northern Germany
par: Wollenhaupt J, et autres
Publié: (2013)

Effects of low-dose tacrolimus therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis
par: Takeo Isozaki, et autres
Publié: (2010)

Recent advances in neutralizing the IL-6 pathway in arthritis
par: Charles J Malemud
Publié: (2009)

Correction to: Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis
par: Michaël Doumen, et autres
Publié: (2021)

Characterization of disease course and remission in early seropositive rheumatoid arthritis: results from the TACERA longitudinal cohort study
Publié: (2021)

Involvement of CX3CL1/CX3CR1 axis in etanercept therapy for patients with active rheumatoid arthritis
par: Michihito Sato, et autres
Publié: (2011)

Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case–control study
par: Gian Luca Erre, et autres
Publié: (2021)

The onset of rheumatoid arthritis following trauma
par: Brawer AE, et autres
Publié: (2016)

The clinical efficacy and safety of certolizumab pegol (CZP) in the treatment of rheumatoid arthritis: focus on long-term use, patient considerations and the impact on quality of life
par: Roy Fleischmann
Publié: (2009)

Incidence density of serious infection, opportunistic infection, and tuberculosis associated with biologic treatment in patients with rheumatoid arthritis &ndash; a systematic evaluation of the literature
par: Tran TN, et autres
Publié: (2013)

Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
par: Mysler E, et autres
Publié: (2021)

Comparison of long-term efficacy between biological agents following tumor necrosis factor inhibitor failure in patients with rheumatoid arthritis: a prospective cohort study
par: Patricia Bogas, et autres
Publié: (2021)

Clinical and serological characteristics of Ecuadorian patients with rheumatoid arthritis
par: Ríos C, et autres
Publié: (2017)

Tuberculosis Arthritis in the Wrist While Using Rituximab for Rheumatoid Arthritis Treatment
par: Ulusoy H, et autres
Publié: (2020)

Different T cells' distribution and activation degree of Th17 CD4+ cells in peripheral blood in patients with osteoarthritis, rheumatoid arthritis, and healthy donors: preliminary results of the MAGENTA CLICAO study
par: Lurati A, et autres
Publié: (2015)

Risk Factors Associated with Methotrexate Intolerance in Rheumatoid Arthritis Patients
par: Almalag H, et autres
Publié: (2020)

Functional Disability and Its Determinants in Ecuadorian Patients with Rheumatoid Arthritis
par: Intriago M, et autres
Publié: (2020)

The patient perspective: arthritis care provided by Advanced Clinician Practitioner in Arthritis Care program-trained clinicians
par: Warmington K, et autres
Publié: (2015)

Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis
par: Bello AE, et autres
Publié: (2017)

Management of rheumatoid arthritis during pregnancy: challenges and solutions
par: Krause ML, et autres
Publié: (2016)